WeberAM, TuchweberB, YousefI, Severe familial cholestasis in North American Indian children: a clinical model of microfilament dysfunction. Gastroenterology1981;81:552–653.
2.
DrouinE, RussoP, TuchweberB, MitchellG, Rasquin-WeberA.North American Indian cirrhosis in children: a review of 30 cases. J Pediatr Gastroenterol Nutr2000;31:395–404.
3.
ChagnonP, MichaudJ, MitchellG, A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. Am J Hum Genet2002;71:1443–1449.
4.
PhillipsMJ, AckerleyCA, SuperinaRA, RobertsEA, FillerRM, LevyGA. Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children. Lancet1996;347:866–868.
5.
VisapääI, FellmanV, VesaJ, GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet2002;71:863–876.
6.
RapolaJ, HeikkilaP, FellmanV.Pathology of lethal fetal growth retardation syndrome with aminoaciduria, iron overload, and lactic acidosis (GRACILE). Pediatr Pathol Mol Med2002;21:183–193.
7.
de VreeJML, JacqueminE, SturmE, Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA1998;95:282–287.
8.
RosmorducO, HermelinB, PouponR.MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology2001;120:1459–1467.
9.
JacqueminE, CresteilD, ManouvrierS, BouteO, HadchouelM.Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet1999;353:210–211.
10.
DixonPH, WeerasekeraN, LintonKJ, Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet2000;9:1209–1217.
11.
StrautnieksS, KniselyAS, GerredS, (2003) Mutations in MDR3 in adult onset cholangiopathy. In: KepplerD, LeuschnerU, PaumgartnerG, StiehlA, eds. Bile Acids: From Genomics to Disease and Therapy. Proceedings, Falk Symposium 129. Dordrecht: Kluwer, pp 184–192
12.
Aagenaes. Hereditary cholestasis with lymphoedema (Aagenaes syndrome, cholestasis-lymphoedema syndrome): new cases and follow-up from infancy to adult age. Scand J Gastroenterol1998;33:335–345.
13.
BullLN, RocheE, SongEJ, Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet2000;67:994–999.
14.
FrühwirthM, JaneckeAR, MüllerT, Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome. J Pediatr2003;142:441–447.
15.
McElhinneyDB, KrantzID, BasonL, Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation2002;106:2567–2574.
16.
ClaytonPT, LeonardJV, LawsonAM, Familial giant cell hepatitis associated with synthesis of 3beta, 7alpha-dihydroxy- and 3beta, 7alpha, 12alpha-trihydroxy-5-cholenoic acids. J Clin Invest1987;79:1031–1038.
17.
SetchellKDR, SuchyFJ, WelshMB, Zimmer-NechemiasL, HeubiJ, BalistreriWF. Delta4-3-oxosteroid 5beta-reductase deficiency described in identical twins with neonatal hepatitis: a new inborn error in bile acid synthesis. J Clin Invest1988;82:2148–2157.
18.
BuchmannMS, KvittingenEA, NazerH, Lack of 3beta-hydroxy-Delta5-C27-steroid dehydrogenase/isomerase in fibroblasts from a child with urinary excretion of 3beta-hydroxy-Delta5-bile acids: a new inborn error of metabolism. J Clin Invest1990;86:2034–2037.
19.
JacqueminE, SetchellKDR, O'ConnellNC, A new cause of progressive intrahepatic cholestasis: 3beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency. J Pediatr1994;125:379–384.
20.
ClaytonPT, CasteelsM, Mieli-VerganiG, LawsonAM. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis. Pediatr Res1995;37:424–431.
21.
SetchellKDR, SchwarzM, O'ConnellNC, Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest1998;102:1690–1703.
22.
AkobengAK, ClaytonPT, MillerV, SuperM, ThomasAG. An inborn error of bile acid synthesis (3β-hydroxy-Δ5-C27-steroid dehydrogenase deficiency) presenting as malabsorption leading to rickets. Arch Dis Child1999;80:463–465.
23.
SetchellKDR, HeubiJE, BoveKE, Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology2003;124:217–232.
24.
BoveKE, DaughertyCC, TysonRW, Bile acid synthetic defects and liver disease. Pediatr Dev Pathol2000;3:1–16.
25.
HondaA, SalenG, SheferS, Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7α-hydroxylase and 27-hydroxylase activities in rat liver. J Lipid Res1999;40:1520–1528.
ClaytonPT, VerripsA, SistermansE, MannA, Mieli-VerganiG, WeversR.Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherited Metab Dis2002;25:501–513.
28.
Di RoccoM, CalleaF, PolliceB, FaraciM, CampianiF, BorroneC.Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families. Eur J Pediatr1995;154:835–839.
29.
EasthamKM, McKiernanPJ, MilfordDV, ARC syndrome: an expanding range of phenotypes. Arch Dis Child2001;85:415–420.
30.
HaniganMH, BarbarM, CullinaneC, (2003) Decreased expression of gamma-glutamyl transpeptidase at the bile canaliculus in arthrogryposis–renal dysfunctioncholestasis syndrome (Abstract). Lab Invest83: 301A
31.
PetersJ, LacailleF, HorslenS, Microvillus inclusion disease treated by small bowel transplantation: development of progressive intrahepatic cholestasis with low serum concentrations of γ-glutamyl transpeptidase activity (Abstract). Hepatology2001;34:213A.
32.
BullLN, CarltonVEH, StrickerNL, Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology1997;26:155–164.
33.
StrautnieksS, ByrneJ, KniselyA, (2001) There must be a third locus for low GGT PFIC (Abstract). Hepatology34: 240A
34.
FloreaniA, MolaroM, MottesM, Autosomal dominant benign recurrent intrahepatic cholestasis (BRIC) unlinked to 18q21 and 2q24. Am J Med Genet2000;95:450–453.
35.
HawardM, KocoshisSA, JaffeR, “Neonatal hepatitis” with giant cells, normal serum γGTP activity, and high serum bile acid concentrations: a phenotype associated with mutations in the gene for the canalicular bile acid transporter, SPGP (Abstract). Lab Invest1999;80:163A.
36.
ChenHL, ChangPS, HsuHC, FICI and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels. J Pediatr2002;140:119–124.
37.
BullMS, FreimerN, CzubkowskiP, Clinical and biochemical features of FIC1 (ATP8B1) and BSEP (ABCB11) disease (Abstract). Hepatology2002;36:310A.
38.
JansenPLM, StrautnieksSS, JacqueminE, Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology1999;117:1370–1379.
39.
StiegerB, FattingerK, MadonJ, Kullak-UblickGA, MeierPJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology2000;118:422–430.
40.
Kullak-UblickGA, KerbR, MüllhauptB, A novel R432T mutation in the bile salt export pump gene (BSEP; ABCB11) is associated with recurrent intrahepatic cholestasis in an adolescent patient (Abstract). Hepatology2001;34:216A.
41.
StrautnieksS, SolerE, ByrneJ, BakerA, VerganiG, ThompsonR.A novel syndrome: progressive familial intrahepatic cholestasis associated with short stature, coloboma and cleft palate (Abstract). Hepatology2001;34:214A.
42.
ScheimannAO, KarntakalW, StrautnieksSS, Presence of mutations in the bile salt excretory pump gene in two families with cholangiocarcinoma and PFIC (Abstract). Hepatology2001;34:208A.
43.
HaniganMH, BullLN, StrautnieksSS, Low serum concentrations of γGT activity in progressive familial intrahepatic cholestasis: evidence for two different mechanisms in PFIC, type 1 (FIC1 disease) and in PFIC, type 2 (BSEP disease) (Abstract). Hepatology2002;36:310A.
44.
UjhazyP, OrtizD, MisraS, Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology2001;34:768–775.
45.
BullLN, van EijkMJT, PawlikowskaL, A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet1998;18:219–223.
46.
KniselyAS, AbukawaD, BullLN, Enterocyte inclusions are associated with diarrhea in both genetically documented progressive familial intrahepatic cholestasis, type 1, and intrahepatic cholestasis characterized by coarsely granular Byler bile (Abstract). Hepatology2000;32:211A.
47.
OshimaT, IkedaK, TakasakaT.Sensorineural hearing loss associated with Byler disease. Tohoku J Exp Med1999;187:83–88.
48.
BhagatG, LobrittoSJ, LefkowitchJH, Allograft steatosis is a feature of progressive familial intrahepatic cholestasis, type 1 (FIC1 disease), treated by orthotopic liver transplantation (OLTX) (Abstract). Hepatology2001;34:209A.
49.
LykavierisP, van MilS, CresteilD, (2003) “Progressive familial intrahepatic cholestasis type I and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation” J Hepatol39: 447–452
50.
BermanL, MarkowitzJ, KahnE, Benign recurrent intrahepatic cholestasis and progressive familial intrahepatic cholestasis linked to PFIC1: points on a continuum (Abstract). Hepatology1997;26:384A.
51.
TygstrupN, SteigBA, JuijnJA, BullLN, HouwenRHJ. Recurrent familial intrahepatic cholestasis in the Faeroe Islands: phenotypic heterogeneity but genetic homogeneity. Hepatology1999;29:506–508.
52.
BullLN, VargasJ, SandovalL, Screening of ATP8B1 (FIC1) in Chilean patients with cholestasis of pregnancy (Abstract). Hepatology2002;36:337A.
53.
MezeyE, BurnsC, BurdickJF, BraineHG. A case of severe benign intrahepatic cholestasis treated with liver transplantation. Am J Gastroenterol2002;97:475–477.
54.
EgawaH, YorifujiT, SumazakiR, KimuraA, HasegawaM, TanakaK.Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resin. Liver Transplant2002;8:714–716.
55.
EibergH, NielsenI-M.Linkage of cholestasis familiaris groenlandica/Byler-like disease to chromosome 18. Int J Circumpolar Health2000;59:57–62.
56.
OrnvoldK, NielsenI-M, PoulsenH.Fatal familial cholestatic syndrome in Greenland Eskimo children: a histomorphological analysis of 16 cases. Virchows Arch [A]1989;415:275–281.
57.
OudeElferink R, PawlikowskaL, LooijeN, Defective regulation of ASBT activity in FIC1 mutant mice (Abstract). Hepatology2002;36:334A.
58.
KlompLWJ, BullLN, KniselyAS, A missense mutation in FIC1 is associated with Greenland familial cholestasis. Hepatology2000;32:1337–1441.
59.
ClaytonRJ, IberFL, RuebnerBH, McKusickVA. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child1969;117:112–124.
60.
van OoteghemNAM, KlompLWJ, van Berge-HenegouwenGP, HouwenRHJ. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol2002;36:439–443.
61.
EppensEF, van MilSWC, de VreeJML, FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol2001;35:436–443.
62.
MuteroA, BullLN, PawlikowskaL, FreimerNB, ScharschmidtBF, LomriN.Cloning and tissue distribution of the rat homologue of the human gene involved in familial intrahepatic cholestasis type 1 (Abstract). Hepatology1998;28:530A.
63.
KurbegovAC, HaasJ, NarkewiczMR, MierauG, SokolRJ. Improved liver histology and ultrastructure following partial external biliary diversion in patients with progressive familial intrahepatic cholestasis (Abstract). Gastroenterology2002;122(Suppl 1:A–645.
BeilerAR. Family History and Geneology of Pioneer Jacob Beiler (1698–1771): Beiler–Boiler–Byler, the Early Generations–Plus. Morgantown, PA: Masthof Press, 998.
66.
McKusickVA. Medical Genetic Studies of the Amish: Selected Papers. Baltimore: Johns Hopkins University Press, 1978.
67.
MaksimakM, O'ConnellNC, SetchellKDR, Evidence for a novel form of progressive intrahepatic familial cho-lestasis in a child of Amish descent (Abstract). Hepatology1997;26:555A.
68.
MortonDH, SalenG, BattaAK, Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol. Gastroenterology2000;119:188–195.
69.
SetchellKDR, HeubiJE, O'ConnellNC, HofmannAF, La-vineJE. Identification of a unique inborn error in bile acid conjugation involving a deficiency in amidation (Abstract). In: PaumgartnerG, StrehlA, GerokW, eds. Bile Acids in Hepatobiliary Diseases: Basic Research and Clinical Application. Dordrecht, Kluwer, 1997:43–47.
70.
ShneiderBL, FoxVL, SchwarzKB, Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology1997;25:1176–1183.
71.
CarltonVEH, HarrisBZ, PuffenbergerE, (2003) Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet34: 91–96